New Zealand markets closed

Vertex Pharmaceuticals Incorporated (VX1.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
416.50+3.05 (+0.74%)
At close: 09:40AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 106.89B
Enterprise value 102.54B
Trailing P/E 31.71
Forward P/E 26.11
PEG ratio (5-yr expected) 0.57
Price/sales (ttm)11.68
Price/book (mrq)8.13
Enterprise value/revenue 11.09
Enterprise value/EBITDA 246.42

Trading information

Stock price history

Beta (5Y monthly) 0.41
52-week change 326.21%
S&P500 52-week change 333.81%
52-week high 3472.00
52-week low 3315.10
50-day moving average 3435.85
200-day moving average 3408.81

Share statistics

Avg vol (3-month) 352
Avg vol (10-day) 320
Shares outstanding 5258.1M
Implied shares outstanding 6259.79M
Float 8257.33M
% held by insiders 10.08%
% held by institutions 195.62%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin -4.74%
Operating margin (ttm)35.34%

Management effectiveness

Return on assets (ttm)12.96%
Return on equity (ttm)-3.24%

Income statement

Revenue (ttm)10.34B
Revenue per share (ttm)40.08
Quarterly revenue growth (yoy)6.10%
Gross profit (ttm)N/A
EBITDA 4.39B
Net income avi to common (ttm)-489.9M
Diluted EPS (ttm)-1.79
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.8B
Total cash per share (mrq)22.45
Total debt (mrq)933.4M
Total debt/equity (mrq)6.32%
Current ratio (mrq)2.52
Book value per share (mrq)57.26

Cash flow statement

Operating cash flow (ttm)-944M
Levered free cash flow (ttm)2.89B